2015
DOI: 10.1016/j.brainres.2015.02.015
|View full text |Cite
|
Sign up to set email alerts
|

Senkyunolide I protects rat brain against focal cerebral ischemia–reperfusion injury by up-regulating p-Erk1/2, Nrf2/HO-1 and inhibiting caspase 3

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
54
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 70 publications
(55 citation statements)
references
References 29 publications
1
54
0
Order By: Relevance
“…Numerous studies have reported that Nrf2 plays a critical role in counteracting inflammation across a variety of experimental models [7]. The main function of Nrf2 is to activate the antioxidant response and induce the transcription of a wide range of genes that are able to counteract the harmful effects of oxidative stress, thus restoring intracellular homeostasis [8].…”
Section: Introductionmentioning
confidence: 99%
“…Numerous studies have reported that Nrf2 plays a critical role in counteracting inflammation across a variety of experimental models [7]. The main function of Nrf2 is to activate the antioxidant response and induce the transcription of a wide range of genes that are able to counteract the harmful effects of oxidative stress, thus restoring intracellular homeostasis [8].…”
Section: Introductionmentioning
confidence: 99%
“…MCAO followed by 72-hr reperfusion was described [49,50]. In addition, various authors showed that pharmacological inhibition or molecular blockage of active caspase-3, including rhEpo administration, significantly decreases infarct size or attenuates the loss of hippocampal CA1 neurons after transient cerebral ischaemia [17,48,49]. We found that after administration of rhEpo, decrease in caspase-3 over-expression was not statistically significant, thus indicating that in our experimental conditions, administration of 5000 IU rhEpo was not able to prevent caspase-3-dependent apoptotic cell death.…”
Section: Discussionmentioning
confidence: 99%
“…, ), ligustilide (Peng et al . , ) and senkyunolide I (Hu, Duan, Liang, & Wang, ) from L. wallichiii are active anti‐cerebral ischemia substances. Future pharmacokinetics research on NMT is required for determining whether the absorbed constituents can be maintained at effective concentrations over time in blood.…”
Section: Discussionmentioning
confidence: 99%
“…Accordingly, 3′methoxypuerarin and daidzein could protect rats against cerebral ischemia-reperfusion injury (Aras et al, 2015;Liu et al, 2010). Moreover, ferulic acid (Cheng et al, 2010), ligustilide (Peng et al, 2013) and senkyunolide I (Hu, Duan, Liang, & Wang, 2015) from L. wallichiii are active anti-cerebral ischemia substances. Future pharmacokinetics research on NMT is required for determining whether the absorbed constituents can be maintained at effective concentrations over time in blood.…”
Section: Analysis Of Constituents Of L Wallichiiimentioning
confidence: 98%